HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study.

AbstractBACKGROUND:
Hemodialysis patients are at high risk of Covid-19, though vaccination has significant efficacy in preventing and reducing the severity of infection. Little information is available on disease severity and vaccine efficacy since the dissemination of the Omicron variant.
METHODS:
In a multi-center study, during a period of the epidemic driven by the Omicron variant, all hemodialysis patients positive for SARS-CoV-2 were identified. Outcomes were analyzed according to predictor variables including vaccination status. Risk of infection was analyzed using a Cox proportional hazards model.
RESULTS:
SARS-CoV-2 infection was identified in 1126 patients including 200 (18%) unvaccinated, 56 (5%) post first dose, 433 (38%) post second dose, and 437 (39%) at least 7 days beyond their third dose. The majority of patients had a mild course but 160 (14%) were hospitalized and 28 (2%) died. In regression models adjusted for age and comorbidity, two-dose vaccination was associated with a 39% (95%CI: 2%-62%) reduction in admissions, but third doses provided additional protection, with a 51% (95%CI: 25%-69%) further reduction in admissions. Among 1265 patients at risk at the start of the observation period, SARS-CoV-2 infection was observed in 211 (17%). Two-dose vaccination was associated with a 41% (95%CI: 3%-64%) reduction in the incidence of infection, with no clear additional effect provided by third doses.
CONCLUSIONS:
These data demonstrate lower incidence of SARS-CoV-2 infection after vaccination in dialysis patients during an Omicron dominant period of the epidemic. Among those developing infection, severe illness was less common with prior vaccination, particularly after third vaccine doses.
AuthorsDamien R Ashby, Ben Caplin, Richard W Corbett, Elham Asgari, Nicola Kumar, Alexander Sarnowski, Richard Hull, David Makanjuola, Nicholas Cole, Jian Chen, Sofia Nyberg, Suzanne Forbes, Kieran McCafferty, Faryal Zaman, Hugh Cairns, Claire Sharpe, Kate Bramham, Reza Motallebzadeh, Kashif Anwari, Tayeba Roper, Alan D Salama, Debasish Banerjee, pan-London Covid-19 renal audit groups
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant) Vol. 37 Issue 10 Pg. 1944-1950 (09 22 2022) ISSN: 1460-2385 [Electronic] England
PMID35767848 (Publication Type: Journal Article, Multicenter Study)
Copyright© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.
Topics
  • COVID-19 (epidemiology, prevention & control)
  • Cohort Studies
  • Humans
  • Renal Dialysis (adverse effects)
  • SARS-CoV-2
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: